Priothera

Developer of therapeutics for the treatment of hematological malignancies

placeDublin, Leinster, Ireland calendar_todayFounded 2020 groups20 employees language priothera.com

Innovation

8 patent families (3 granted) — focus: Human necessities; filing pace slowing. Cited 491 times.

YearFilings
20171
20181
20201
20213
20225
20235
20243
20256

Social engagement

Social engagement: 2.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Fountain Healthcare Partners, Healthcap.

Investor typeCountShare
Venture capital350%
Private equity117%
Bank & private debt117%
Other / undisclosed117%

Recent activity

9 Jun 2026
Event
European Hematology Association (EHA)2026 Congress
18 May 2026
Event
GITMO 2026 Annual Meeting
25 Mar 2026
Recognition
Coming soon